Is COVID-19 really improving pharma's reputation? Takeda survey says not so much
Thinking pharma might earn a halo with its COVID-19 work? Not so fast, Takeda says. Its recent U.K. study finds only an incremental boost in positive consumer sentiment. Only 17% of adults surveyed in October agreed that their perception of the pharma industry has improved during the pandemic, while the majority (54%) said their opinion hasn't changed. Ipsos MORI fielded the study with adults in the U.K. and also with healthcare professionals. “Whilst there might be this perception it’s improved, there’s actually a lot of work to do to get down to the general public to change their perceptions,” Jon Neal, Takeda managing director in the U.K. and Ireland, said.
FiercePharma - December 17, 2020View the full story here: https://www.fiercepharma.com/marketing/takeda-u-k-survey-finds-only-minor-pharma-reputation-gains-during-pandemic